June 24, 2026
5,449
768
93
15.80%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
6:54Now PlayingA mystery 79-year-old man reportedly received compassionate-use access to Eli Lilly’s experimental weight-loss drug retatrutide, even though the program is meant for patients with no other options and millions of Americans cannot legally get the treatment. The White House insists the patient was not Trump, but its furious response only fueled questions about why someone so connected was moved to the front of a line built for the desperate and the dying. Whether Trump was involved or not, the scandal is the same: powerful people get secret doors, special approvals, and miracle-drug access while everyone else gets a waiting list, a denial, or a dangerous knockoff. Ring of Fire's Josh G. explains.
Subscribe to stay connected to our stories
Support us by becoming a member on YouTube
Find us on social media!
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.